Notis-McConarty Edward’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.74M | Buy |
4,062
+598
| +17% | +$606K | 1.86% | 22 |
|
|
2025
Q4 | $3.72M | Buy |
3,464
+1,041
| +43% | +$995K | 1.73% | 20 |
|
|
2025
Q3 | $1.85M | Buy |
2,423
+711
| +42% | +$529K | 0.86% | 35 |
|
|
2025
Q2 | $1.33M | Buy |
1,712
+1,424
| +494% | +$1.11M | 0.65% | 37 |
|
|
2025
Q1 | $238K | Buy |
+288
| New | +$240K | 0.12% | 71 |
|
|
2024
Q2 | – | Sell |
-349
| Closed | -$272K | – | 91 |
|
|
2024
Q1 | $272K | Sell |
349
-75
| -18% | -$53.4K | 0.11% | 82 |
|
|
2023
Q4 | $247K | Sell |
424
-41
| -9% | -$23.9K | 0.1% | 85 |
|
|
2023
Q3 | $250K | Sell |
465
-10
| -2% | -$5.15K | 0.1% | 89 |
|
|
2023
Q2 | $223K | Buy |
+475
| New | +$199K | 0.08% | 91 |
|
|
2023
Q1 | – | Sell |
-550
| Closed | -$201K | – | 96 |
|
|
2022
Q4 | $201K | Sell |
550
-70
| -11% | -$24.8K | 0.08% | 96 |
|
|
2022
Q3 | $201K | Sell |
620
-50
| -7% | -$15.8K | 0.09% | 96 |
|
|
2022
Q2 | $217K | Sell |
670
-60
| -8% | -$18K | 0.09% | 99 |
|
|
2022
Q1 | $209K | Hold |
730
| – | – | 0.07% | 101 |
|
|
2021
Q4 | $202K | Buy |
+730
| New | +$185K | 0.07% | 103 |
|
|
2017
Q4 | – | Sell |
-3,000
| Closed | -$257K | – | 90 |
|
|
2017
Q3 | $257K | Hold |
3,000
| – | – | 0.16% | 83 |
|
|
2017
Q2 | $247K | Sell |
3,000
-50
| -2% | -$4.08K | 0.16% | 85 |
|
|
2017
Q1 | $256K | Sell |
3,050
-282
| -8% | -$22.6K | 0.17% | 83 |
|
|
2016
Q4 | $245K | Sell |
3,332
-24
| -0.7% | -$1.79K | 0.17% | 87 |
|
|
2016
Q3 | $269K | Sell |
3,356
-150
| -4% | -$12K | 0.18% | 87 |
|
|
2016
Q2 | $276K | Hold |
3,506
| – | – | 0.19% | 82 |
|
|
2016
Q1 | $252K | Sell |
3,506
-376
| -10% | -$28.4K | 0.18% | 87 |
|
|
2015
Q4 | $327K | Sell |
3,882
-312
| -7% | -$25.9K | 0.23% | 81 |
|
|
2015
Q3 | $351K | Sell |
4,194
-112
| -3% | -$9.46K | 0.26% | 80 |
|
|
2015
Q2 | $359K | Sell |
4,306
-200
| -4% | -$15.2K | 0.24% | 86 |
|
|
2015
Q1 | $328K | Sell |
4,506
-200
| -4% | -$14.2K | 0.23% | 89 |
|
|
2014
Q4 | $325K | Hold |
4,706
| – | – | 0.22% | 89 |
|
|
2014
Q3 | $305K | Hold |
4,706
| – | – | 0.21% | 88 |
|
|
2014
Q2 | $292K | Hold |
4,706
| – | – | 0.19% | 89 |
|
|
2014
Q1 | $277K | Sell |
4,706
-80
| -2% | -$4.46K | 0.19% | 86 |
|
|
2013
Q4 | $244K | Buy |
+4,786
| New | +$240K | 0.17% | 93 |
|
Other funds holding LLY
VCM
VPM
Notis-McConarty Edward's LLY Position: Q1 2026 in Review
Notis-McConarty Edward increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $606K and bringing the position to 4,062 shares worth $3.74M. The position accounts for 1.86% of the portfolio, ranked #22.
Notis-McConarty Edward first reported a position in LLY in Q4 2013 and has held it in 30 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Notis-McConarty Edward held 4,062 shares of Eli Lilly worth $3.74M as of Q1 2026.
- Notis-McConarty Edward bought 598 Eli Lilly shares in Q1 2026, an estimated $606K.
- Eli Lilly made up 1.86% of Notis-McConarty Edward's portfolio in Q1 2026, its #22 holding.
- Notis-McConarty Edward first reported a position in Eli Lilly in Q4 2013 and has held it in 30 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Notis-McConarty Edward's 13F filing for Q1 2026, filed 8 May 2026.